MusclePharm Corporation Business Combination, Consideration Transferred
MusclePharm Corporation reported Business Combination, Consideration Transferred of $9.84 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-10-31.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2014-10-31
- 2014-06-30: Business Combination, Consideration Transferred 6 month $9.84M.
| Period end | Business Combination, Consideration Transferred 6 month |
|---|---|
| 2014-06-30 | $9.84M 10-Q · filed 2014-10-31 |